000			02203cam a2200361 a 4500
003			EG-GiCUC
005			20250223030615.0
008			120421s2011 ua d f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.11.18.M.Sc.2011.Az.C
100	0		_aAzza Shehata Ragab Sarhan
245	1	0	_aComparative study between myeloablative conditioning and reduced intensity conditioning regimens for allogenic stem cell transplantation in myelodysplastic syndromes / _cAzza Shehata Ragab Sarhan ; Supervised Omar Abdelrahman Fahmy , Mohamed Abdelmooti Samra , Raafat Mohamed Abdelfattah
246	1	5	_aزرع النخاع باستخدام العلاج الكيميائي المدمر لخلايا النخاع العظمي مقارنة باستخدام العلاج الكيميائي مخفف الشدة في علاج متلازمة خلل نمو النخاع العظمي
260			_aCairo : _bAzza Shehata Ragab Sarhan , _c2011
300			_a192 P. : _bcharts ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Medicine. - Department of Internal Medicine
520			_aStem cell transplantation offers potentially curative therapy for patients with myelodysplastic syndrome. A broad scale regimens, ranging from "modified" conventional to reduced intensity to non-myeloablative regimens, has been developed and used successfully; one size does not appear to fit all. Rather, patient age, co-morbid conditions, disease stage, ferretin level, presence and severity of myelofibrosis, non-transplant chemotherapy, type of donor, source of stem cell, and other factors, all affect the decision regarding transplantation and impact on outcome
530			_aIssued also as CD
653		4	_aConditioning regimen
653		4	_aMyelodysplastic syndromes
653		4	_aNonmyeloablative
700	0		_aMohamed Abdelmooti Samra , _eSupervisor
700	0		_aOmar Abdelrahman Fahmy , _eSupervisor
700	0		_aRaafat Mohamed Abdelfattah , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
902			_a2
905			_aNazla _eRevisor
905			_aSamia _eCataloger
942			_2ddc _cTH
999			_c38221 _d38221